A case of surgical intervention for refractory pneumothorax associated with pulmonary metastases from osteosarcoma during pazopanib administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case of surgical intervention for refractory pneumothorax associated with pulmonary metastases from osteosarcoma during pazopanib administration

Published:2024-01-15 Issue:1 Volume:38 Page:50-54
ISSN:0919-0945
Container-title:The Journal of the Japanese Association for Chest Surgery
language:en
Short-container-title:Jpn J Chest Surg

Author:

Dobashi Ryota¹²,Ishihara Shunta¹,Shimomura Masanori¹,Tsunezuka Hiroaki³,Ikebe Satoshi⁴,Inoue Masayoshi¹

Affiliation:

1. Division of Thoracic Surgery, Department of Surgery, Kyoto Prefectural University of Medicine

2. Department of Thoracic Surgery, Uji Tokushukai Hospital

3. Department of Thoracic Surgery, Otsu City Hospital

4. Department of Thoracic Surgery, Fukuchiyama City Hospital

Publisher

Japanese Association for Chest Surgery

Link

https://www.jstage.jst.go.jp/article/jacsurg/38/1/38_50/_pdf

Reference12 articles.

1. 1. Van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo controlled phase 3 trial. Lancet 2012; 379: 1879-86.

2. 2. Nakano K, Motoi N, Tomomatsu J, Gokita T, Ae K, Tanizawa T, et al. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis. BMC Cancer 2016; 16: 750.

3. 3. Verschoor AJ, Gelderblom H. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series. Clin Sarcoma Res 2014; 4: 14.

4. 4. Teshima Y, Nomura S, Fukasawa N. Postmarketing observational study of pazopanib in patients with metastatic soft tissue sarcoma in Japan. Jpn J Clin Oncol 2021; 51: 612-21.

5. 5. Sabath B, Muhammad HA, Balagani A, Ost DE, Vakil E, Ahmed T, et al. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study. BMC cancer 2018; 18: 937.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3